stuartlpbi | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Advertisements

Feeds:: Posts; Comments

About: Stuart Cantor

Website: http://stuartlpbi.wordpress.com
Details: I have a Ph.D. in pharmaceutical sciences and my expertise is in solid oral dosage formulation development and controlled-release technologies. I also have a deep background in intellectual property in the areas of chemistry, pharma, medical device, and biotech.

Posts by Stuart Cantor:

February 8, 2016 Bio-MEMS Technologies: Devices, Tissue Engineering & Drug Delivery, Presentation by Stuart Cantor, Ph.D. on 2/4/16

Advertisements

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,264 other followers
Recent Posts
- LIVE – OCTOBER 17 – DAY 2- Koch Institute Immune Engineering Symposium 2017, MIT, Kresge Auditorium October 17, 2017
- LIVE – OCTOBER 16 – DAY 1- Koch Institute Immune Engineering Symposium 2017, MIT, Kresge Auditorium October 14, 2017
- 2017 Nobel prize in chemistry given to Jacques Dubochet, Joachim Frank, and Richard Henderson for developing cryo-electron microscopy October 11, 2017
- Ferritin Cage Enzyme Encapsulation as a New Platform for Nanotechnology October 9, 2017
- Systemic Inflammatory Diseases as Crohn’s disease, Rheumatoid Arthritis and Longer Psoriasis Duration May Mean Higher CVD Risk October 9, 2017
- QIAGEN – International Leader in NGS and RNA Sequencing October 8, 2017
- The Role of Exosomes in Metabolic Regulation October 8, 2017
- Development of 3D Human Tissue Models Awarded NIH Grants Worth $15M October 5, 2017
- Brain Surgeons Use 3D printing to Practice October 4, 2017
- 3D-Printed Body Parts Could Replace Cadavers for Medical Training October 4, 2017
Archives
Archives
Categories
Categories
Meta